Lawrence Otto Klein

Chief Business Officer, CRISPR Therapeutics.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Sep 15, 2026Sold 2,452 shares at $95.71 of Oruka Therapeutics, Inc.⁷
Sep 1, 2026Sold 4,800 shares at $92.44 of Oruka Therapeutics, Inc.¹¹
Sep 1, 2026Sold 63,596 shares at $91.90 of Oruka Therapeutics, Inc.¹¹
Sep 1, 2026Sold 6,604 shares at $90.79 of Oruka Therapeutics, Inc.¹¹
Sep 1, 2026Exercised options 75,000 shares at $7.80 of Oruka Therapeutics, Inc.¹¹
Jun 15, 2026Sold 1,729 shares at $69.69 of Oruka Therapeutics, Inc.¹²
Mar 16, 2026Sold 1,729 shares at $41.30 of Oruka Therapeutics, Inc.¹³
Jan 23, 2026Granted 76,700 shares of Oruka Therapeutics, Inc.¹⁴
Oct 12, 2022Granted 24,500 shares of Jasper Therapeutics, Inc.¹⁰
Mar 14, 2022Shares withheld for tax 1,229 shares at $61.08 of CRISPR Therapeutics⁸
Mar 11, 2022Exercised options 3,000 shares of CRISPR Therapeutics⁸
Mar 11, 2022Shares withheld for tax 1,883 shares at $62.56 of CRISPR Therapeutics⁸
Mar 10, 2022Exercised options 4,584 shares of CRISPR Therapeutics⁸
Dec 6, 2021Shares withheld for tax 11,185 shares at $69.17 of CRISPR Therapeutics¹⁵
Dec 3, 2021Exercised options 26,667 shares of CRISPR Therapeutics¹⁵

The numbers on this page point here. Each one links to the record it came from.